SHOWANDA MCKAY: Open Payments
NPI 1063866077 · SENATOBIA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$198 in 10 payments from 7 companies in 2025. Trend: 2023 $442 · 2024 $628 · 2025 $198
Food & beverage: $198
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $68 |
| Lilly USA, LLC | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: FREESTYLE LIBRE 3, MOUNJARO, FARXIGA, Kerendia, Dexcom G6 Transmitter, Veozah.
Industry payments across MS — which companies pay providers there.
